Latticework
← All super investors

Samantha McLemore

Patient Capital Management

$3.01B
disclosed 13F portfolio · 39 positions
top-5 concentration31%
Q2 2026 · filed Aug 13, 2026

Samantha McLemore (Patient Capital Management) discloses a $3.01B portfolio across 39 US-listed positions in the latest 13F filing (2026Q2, filed Aug 13, 2026). The largest holding is RPRX at 6.7% of the book. The biggest move of the quarter: added 42% to the CHYM share count (position now $84M). Mechanically cloning this 13F returned 11.8%/yr over the past 4.4 years, versus 13.9%/yr for the S&P 500 across that identical 4.4-year window.

Share𝕏in

Holdings (39) · click any column to sort

Sort
  • port6.7%
    val$202M
    Royalty Pharma Plc
    this Q hold·11q
  • 2C
    port6.5%
    val$196M
    Citigroup Inc
    this Q hold·18q
  • port6.2%
    val$188M
    Alphabet Inc-cl A
    this Q hold·19q
  • port6.0%
    val$182M
    Unitedhealth Group Inc
    this Q hold·5q
  • port5.4%
    val$162M
    Amazon.com Inc
    this Q hold·19q
  • port4.7%
    val$142M
    Nvidia Corp
    this Q hold·10q
  • port4.2%
    val$128M
    Cvs Health Corp
    this Q hold·12q
  • port4.2%
    val$127M
    Norwegian Cruise Line Hldgs
    this Q hold·19q
  • port4.1%
    val$123M
    Qxo Inc
    this Q hold·8q
  • 10ET
    port3.9%
    val$116M
    Energy Transfer LP
    this Q hold·19q
  • 11IAC
    port3.7%
    val$112M
    Iac Inc
    this Q hold·13q
  • port3.6%
    val$109M
    Precigen Inc
    this Q hold·19q
  • 13UAL
    port3.3%
    val$99M
    United Airlines Holdings Inc
    this Q hold·17q
  • port3.2%
    val$96M
    Crocs Inc
    this Q hold·11q
  • port3.2%
    val$96M
    Meta Platforms Inc-class A
    this Q hold·19q
  • port2.8%
    val$84M
    Chime Financial Inc-cl A
    this Q +42%·3q
  • port2.5%
    val$74M
    Adobe Inc
    this Q +21%·2q
  • port2.5%
    val$74M
    Seadrill Ltd
    this Q hold·11q
  • 19GPN
    port2.3%
    val$68M
    Global Payments Inc
    this Q New·1q
  • port2.2%
    val$68M
    Coinbase Global Inc -class A
    this Q hold·18q
  • port2.1%
    val$62M
    Fidelity Wise Origin Bitcoin
    this Q +244%·10q
  • port2.0%
    val$61M
    Biogen Inc
    this Q -25%·10q
  • port2.0%
    val$61M
    Illumina Inc
    this Q -37%·11q
  • 24GM
    port1.6%
    val$49M
    General Motors CO
    this Q hold·19q
  • 25UBS
    port1.6%
    val$47M
    Ubs Group AG
    this Q -23%·14q
  • port1.6%
    val$47M
    Fiserv Inc
    this Q hold·16q
  • port1.4%
    val$43M
    Expedia Group Inc
    this Q hold·17q
  • 28OMF
    port1.4%
    val$43M
    Onemain Holdings Inc
    this Q hold·19q
  • 29DAL
    port1.3%
    val$40M
    Delta Air Lines Inc
    this Q -22%·19q
  • 30JD
    port1.2%
    val$35M
    Jd.com Inc-adr
    this Q hold·7q
  • port0.9%
    val$27M
    Sofi Technologies Inc
    this Q hold·19q
  • 32TEM
    port0.8%
    val$23M
    Tempus AI Inc-cl A
    this Q hold·5q
  • 33JPM
    port0.3%
    val$10M
    Jpmorgan Chase & CO
    this Q hold·19q
  • 34G3934V109
    port0.2%
    val$5M
    Genius Sports Limited
    this Q New·1q
  • 35NE
    port0.1%
    val$4M
    Noble Corp Plc
    this Q -93%·5q
  • port0.1%
    val$2M
    Dave & Buster's Entertainmen
    this Q -82%·8q
  • 37APA
    port0.1%
    val$2M
    Apa Corp
    this Q hold·7q
  • port<0.1%
    val$1M
    Lennar Corp - B Shs
    this Q hold·17q
  • 39SPY
    port<0.1%
    val$792K
    SS Spdr S&p 500 Etf Trust-us
    this Q hold·8q

Beyond the 13F

as of 2026-04-30

Across Samantha McLemore’s registered funds — $800M disclosed in SEC Form N-PORT — just 97.7% sits in US-listed equity, the only slice a 13F reports. The other $19M is other assets — none of which a 13F can show.

These registered funds hold $800M against the $3.01B Samantha McLemore reports on its 13F, so this describes those funds, not the whole firm. Everything the manager runs outside a registered fund — separate accounts, private vehicles — files no N-PORT and is not counted here.

US-listed equity (13F-eligible) · $782MOther · $19M

Where the hidden money is

Largest positions no 13F shows

SANOFI SA · France · USD$19M

From SEC Form N-PORT, which registered funds file with their full portfolio — every currency, asset class and short. Covers 1 fund. The percentage above is the composition of those funds, not a ratio between two filings: a 13F spans every discretionary account but only US-listed securities, while N-PORT covers only the registered funds but every asset inside them — different universes, so the totals are not comparable (the 13F itself reports $3.01B for 2026-06-30). None of this feeds the backtest above, which stays a pure 13F clone.

2026Q2 moves, by size (12)(expand ↓)
  • ADDCHYM
    2.8%
    Chime Financial Inc-cl A
    Δ +42%·$84M
  • ADDADBE
    2.5%
    Adobe Inc
    Δ +21%·$74M
  • TRIMBIIB
    2.0%
    Biogen Inc
    Δ -25%·$61M
  • TRIMILMN
    2.0%
    Illumina Inc
    Δ -37%·$61M
  • TRIMNE
    0.1%
    Noble Corp Plc
    Δ -93%·$4M
  • NEWGPN
    2.3%
    Global Payments Inc
    Δ +100%·$68M
  • ADDFBTC
    2.1%
    Fidelity Wise Origin Bitcoin
    Δ +244%·$62M
  • TRIMUBS
    1.6%
    Ubs Group AG
    Δ -23%·$47M
  • EXITIBIT
    1.6%
    Ishares Bitcoin Trust Etf
    Δ -100%·$0
  • TRIMDAL
    1.3%
    Delta Air Lines Inc
    Δ -22%·$40M
  • TRIMPLAY
    0.1%
    Dave & Buster's Entertainmen
    Δ -82%·$2M
  • NEWG3934V109
    0.2%
    Genius Sports Limited
    Δ +100%·$5M

About Samantha McLemore

Samantha McLemore founded Patient Capital Management after a long tenure at Legg Mason working alongside Bill Miller, whose influence is visible in the portfolio's structure: a moderate 38-position book with roughly 28% in the top five holdings, blending large-cap compounders like GOOGL and AMZN with more contrarian positions such as RPRX and C. The style is best described as concentrated-ish long-only value with a growth tolerance — willing to hold businesses that screen expensive on trailing multiples if the forward earnings power justifies it, a Miller inheritance. What a 13F reader should keep in mind: the disclosed long equity book is likely a reasonable representation of the strategy, since Patient Capital does not appear to run a significant parallel short or derivatives book, but the 45-day lag still matters for a portfolio this size. The clone backtest showing roughly -3% annual excess return versus SPY over four-plus years reflects a period when quality-growth crowding made that Miller-style flexibility a headwind rather than an edge.

2026Q2 brief

Samantha McLemore's Patient Capital Management ($3.01B, 39 positions) made a few telling moves in Q2 2026 that blend macro skepticism with selective tech and crypto conviction. The standout addition is FBTC (a Bitcoin ETF), which more than tripled (+244%) to 2.1% of the portfolio—while simultaneously exiting IBIT (BlackRock's Bitcoin ETF, previously 1.6%). The net effect is a consolidation of crypto exposure rather than an exit, but the swap between Bitcoin ETF wrappers is worth flagging. ADBE was added 21% to 2.5%, a contrarian lean into a software name that has underperformed peers. The new position in GPN (Global Payments, 2.3%) fits a pattern of distressed fintech interest. On the trim side, near-exits from NE (−93%) and PLAY (−82%) signal a clean-up of smaller, less-conviction ideas, while ILMN was cut 37%—a continued retreat from genomics. McLemore holds UNH at 6.0% despite sector pressure on managed care, a contrarian stance shared by few peers at this weight. Watch whether GPN and the managed-care names (UNH, CVS) are built up meaningfully in Q3 as potential high-conviction adds.

AI-generated. Not investment advice.

Filing history

Samantha McLemore's disclosed 13F portfolio value and position count by quarter — the trajectory across every SEC filing.

Disclosed portfolio value · Q3 2023Q2 2026now $3.05B · peak $3.05B (Q2 2026)
Q3 2023Q2 2024Q2 2025Q2 2026
QuarterPositionsPortfolio value
Q2 2026 — what changed →40
$3.05B
Q1 2026 — what changed →40
$2.74B
Q4 2025 — what changed →40
$2.59B
Q3 2025 — what changed →41
$2.50B
Q2 2025 — what changed →40
$2.22B
Q1 2025 — what changed →39
$1.94B
Q4 2024 holdings43
$2.17B
Q3 2024 holdings41
$2.04B
Q2 2024 holdings40
$1.88B
Q1 2024 holdings42
$2.05B
Q4 2023 holdings43
$1.89B
Q3 2023 holdings42
$1.70B

Values as disclosed at each quarter end. Older filings on EDGAR.

Multibaggers Samantha McLemore held

Stocks up 5x or more since Samantha McLemore first held them at conviction size — the holding record behind the returns. Longest unbroken run and largest book weight are shown for each.

  • NVDA488xNVIDIA CORP9q straight · peak 4.73% · still holds
  • OVV27.4xOVINTIV INC8q straight · peak 6.22%
  • AMZN13.8xAMAZON.COM INC18q straight · peak 6.48% · still holds
  • CVNA13.4xCARVANA CO1q straight · peak 0.51%
  • GOOGL10.1xALPHABET INC-CL A18q straight · peak 7.03% · still holds
  • META10.0xMETA PLATFORMS INC-CLASS A18q straight · peak 4.81% · still holds

Six biggest of 8. Price multiple since the first quarter we observed a conviction holding (2014Q1 at the earliest), not Samantha McLemore's realized return — entry price and trades between filings aren't disclosed. Peak weight is share of disclosed US 13F book. All 129 multibaggers the cohort held →

Frequently asked questions

What stocks does Samantha McLemore own?
As of 2026Q2, Samantha McLemore's 13F discloses 39 positions worth $3.01B. The top five holdings: RPRX (6.7%), C (6.5%), GOOGL (6.2%), UNH (6.0%), AMZN (5.4%). 13F filings cover long US-listed equities only — cash, bonds, shorts, and non-US positions are not disclosed.
What did Samantha McLemore buy this quarter?
In 2026Q2, the filing shows 2 new positions and 3 additions to existing holdings. The largest positions touched by buying: CHYM, ADBE, GPN, FBTC.
How big is Samantha McLemore's portfolio?
$3.01B across 39 positions per the latest 13F (filed Aug 13, 2026). The top five holdings account for 31% of the disclosed book.

Similar portfolios

Explore more

Long US equity 13F-HR filings only — no shorts, no derivatives. SEC filings at EDGAR (CIK 0001854794). Not investment advice.